AMMECR1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.431400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.503600E-01
Normal-vs-Stage2
9.416400E-01
Normal-vs-Stage3
1.100240E-01
Normal-vs-Stage4
3.752200E-01
Stage1-vs-Stage2
8.877200E-01
Stage1-vs-Stage3
1.110230E-01
Stage1-vs-Stage4
3.114800E-01
Stage2-vs-Stage3
1.021180E-01
Stage2-vs-Stage4
9.232100E-02
Stage3-vs-Stage4
9.040400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.191800E-01
Normal-vs-AfricanAmerican
6.963800E-01
Normal-vs-Asian
9.616400E-01
Caucasian-vs-AfricanAmerican
5.348400E-01
Caucasian-vs-Asian
7.558400E-01
AfricanAmerican-vs-Asian
8.042800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.488000E-01
Normal-vs-Female
8.215800E-01
Male-vs-Female
2.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.157000E-01
Normal-vs-Age(41-60Yrs)
5.910600E-01
Normal-vs-Age(61-80Yrs)
7.059200E-01
Normal-vs-Age(81-100Yrs)
7.287800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.400600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.125800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.860800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.236250E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.290250E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.820400E-01
Normal-vs-Daily Drinker
4.353000E-01
Normal-vs-Weekly Drinker
8.282000E-01
Normal-vs-Occasional Drinker
8.450800E-01
Normal-vs-Social Drinker
8.145800E-01
Non Drinker-vs-Daily Drinker
2.135400E-01
Non Drinker-vs-Weekly Drinker
8.614400E-01
Non Drinker-vs-Occasional Drinker
4.823600E-01
Non Drinker-vs-Social Drinker
9.000400E-01
Daily Drinker-vs-Weekly Drinker
4.108200E-01
Daily Drinker-vs-Occasional Drinker
9.749800E-02
Daily Drinker-vs-Social Drinker
3.218000E-01
Weekly Drinker-vs-Occasional Drinker
4.940400E-01
Weekly Drinker-vs-Social Drinker
9.564400E-01
Occasional Drinker-vs-Social Drinker
4.815600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.045400E-01
Normal-vs-Grade 2
1.914610E-01
Normal-vs-Grade 3
1.331440E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.721640E-02
Grade 1-vs-Grade 3
3.242300E-03
Grade 1-vs-Grade 4
6.045400E-01
Grade 2-vs-Grade 3
1.809160E-01
Grade 2-vs-Grade 4
1.914610E-01
Grade 3-vs-Grade 4
1.331440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.111400E-01
Normal-vs-NonDiabetic
8.860200E-01
Diabetic-vs-NonDiabetic
1.377420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.096400E-01
Normal-vs-NoPancreatitis
8.035200E-01
Pancreatitis-vs-NoPancreatitis
9.218400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.038600E-01
Normal-vs-N1
9.599400E-01
N0-vs-N1
3.096600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.372200E-01
Normal-vs-TP53-NonMutant
8.598200E-01
TP53-Mutant-vs-TP53-NonMutant
8.523200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
